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Recently, large-scale benign copy-number variations (CNVs)—encompassing over 12% of the genome and containing genes considered
to be dosage tolerant for human development—were uncovered in the human population. Here we present a family with a novel auto-
somal-dominantly inherited syndrome characterized by microtia, eye coloboma, and imperforation of the nasolacrimal duct. This phe-
notype is linked to a cytogenetically visible alteration at 4pter consisting of ﬁve copies of a copy-number-variable region, encompassing
a low-copy repeat (LCR)-rich sequence. We demonstrate that the ~750 kb amplicon occurs in exact tandem copies. This is the ﬁrst
example of an ampliﬁed CNV associated with a Mendelian disorder, a discovery that implies that genome screens for genetic disorders
should include the analysis of so-called benign CNVs and LCRs.We examined a large family with autosomal-dominant
inheritance of microtia and nasolacrimal-duct imperfora-
tion associated with variable degrees of eye coloboma (Fig-
ure 1). High-resolution cytogenetic analysis was performed
on nine family members (II:3, II:4, II:8, II:5, III:3, III:4,
III:5, III:6, III:7) and revealed an aberrant karyotype 46,
XY, add(4)(pter) segregating with the phenotype.
Two-point linkage analysis (Fastlink package)1,2 with a
series of polymorphic markers derived from 4pter resulted
in a LOD score > 2.4 for markers D4S2923, D4S1582, and
D4S2946, with a highest LOD score of 3.03 at w ¼ 0 for
D4S2923 (Figure 2). Inferring the genotype of patient II:5
for D4S2923 raises the maximum LOD score to 3.2. None
of the informative markers were duplicated or deleted.
With the visible alteration used as a rare marker, the max-
imum possible LOD score of 3.6 was obtained. In addition,
full genome analysis using the 250K Nsp1 SNP arrays
(Affymetrix, Santa Clara, California) of the affected and
nonaffected family members was performed. Parametric
linkage (penetrance 99% and phenocopy rate 1%) was per-
formed with Genehunter and Dchip softwares. Only the
4p16 locus had a LOD score > 3. The highest LOD score of
3.1–3.8 was obtained for a 12.8 Mb region corresponding
to that from the marker analysis (8.2–21.0 Mb) (Figure 3).
Material was not available from II:9 member of the family.
Multicolor ﬂuorescent in situ hybridization (MFISH;
Metasystems)using24whole-chromosomepaintingprobes
and FISH using a chromosome 4-speciﬁc paint (Vysis,
Downers Grove, Illinois) showed that the entire additional
material was derived from 4p, exclusively (Figures 4B). Sub-
sequent chromosome 4 multicolor banding3 revealed an
increased signal, suggesting that the apparent rearrange-
ment was caused by a duplication or ampliﬁcation withinThe Am4p15–4p16 (Figure 4C). In order to ﬁne-map this region,
we performed array comparative genomic hybridization
(CGH)with 1Mb resolution4,5 and subsequently a contigu-
ous 4p-speciﬁc tiling-path array.6 While the result from the
1Mb arraywas normal, four out of six contiguous clones on
the chromosome 4p tiling-path array presented with ratios
slightly above the set threshold (four times the standard
deviation) (Figure 4D). FISH analysis with all six clones
showed stronger signals at one of the p arms of chromo-
some 4 in the affected patients, whereas signal intensities
were equal in both chromosomes in the nonaffected family
members. Furthermore, all but one clone (RP11-637J21)
hybridized at multiple genomic loci (Figure 5A).
To delineate the size and determine the number of cop-
ies present in the ampliﬁed region, we performed a series
of quantitative PCR (Q-PCR) experiments (Applied Biosys-
tems). The number of alleles present was quantiﬁed with
the comparative threshold cycle (dCt) method with p53
as reference gene.7 The distal breakpoint was found to be
located between 8.670 Mb and 8.684 Mb, and the proxi-
mal breakpoint was found between 9.424 Mb and 9.426
Mb. The dCt values for the primer pairs within the ampli-
ﬁed region corresponded to a 3-fold difference between the
affected family members and the normal controls. On the
basis of the Q-PCR proﬁles, we concluded that the ampli-
ﬁed region is present in six copies in all affected family
members. Moreover, the same copy number was reported
by all seven primer pairs used (Table 1) (Figure 5C).
To determine the orientation of the additional sequences
in the affected family members, we performed a series of
PCRs with various combinations of primers at both sides
of the breakpoint (for the sequence of the primers, see
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only obtained when the forward primer from the distal
side and the reverse primer from the proximal side were
combined, showing that at least two fragments are in tan-
dem. No ampliﬁcation occurred between the other two
combinations of primers. We did obtain a fragment for
the affected family members studied, whereas no ampliﬁ-
cation occurred in the nonaffected family members or in
controls (Figure 6B). The product of the breakpoint-span-
ning PCR was sequenced. We found a unique breakpoint
Figure 1. Phenotype of the Patients
(A) Right microtia, (B) imperforated naso-
lacrimal duct, (C) left-eye coloboma of the
iris, and (D) chorioretinal coloboma.
Figure 2. Linkage of the Phenotype with 4p15-4p16.1
Primer sequences for linkage analysis were as published (GDB Human Genome Database). The region between the red lines is linked with
the phenotype. Patients with eye coloboma are indicated by a filled upper-left square, patients with absent canaliculi are indicated by
a filled lower-left square, and patients with microtia are indicated by filled upper- and lower-right squares. In those family members
karyotyped, it is indicated whether only normal chromosomes 4 were identified (N) or an abnormal chromosome 4 was detected
(4pþ). No material was available from the II:9 family member.
for the proximal side at 9.42 Mb and
a breakpoint in a low-copy repeat
(LCR) region for the distal side located
at 8.673Mb and at 8.679Mb. Further-
more, we identiﬁed at the junction
a three-nucleotide sequence overlap
(Figure 6C). To conﬁrm these results,
we also performed Southern-blot
analysis (Figure 6D). After digestion
of the genomic DNA with BglII and
Stu I enzymes (Roche Applied Sci-
ence), the fragments were hybridized
against a PCR-generated probe from the ampliﬁed region.
In the affected family members, a single novel fragment,
corresponding in size with tandem copies of the region,
was observed with 2-fold-higher intensities compared to
the wild-type. In the nonaffected family members and
the normal controls, only the wild-type fragment was ob-
served. In summary, affected family members carry on
one chromosome 4p ﬁve tandem copies of an identical
~750 kb DNA fragment.182 The American Journal of Human Genetics 82, 181–187, January 2008
Sequence analysis revealed that this region encompasses
LCRs known to be copy number variable in the normal
population and harboring multiple paralogous sites in
the genome. Gains and losses of all annotated genes
in the region were described not only in 270 HapMap indi-
viduals, but also in other populations screened for copy-
number variations (CNVs)8–13 (Figure 5B). However, no in-
dividual carrying this speciﬁc 750 kb amplicon has been
reported in any of these studies. To exclude the possibility
that this speciﬁc 750 kb amplicon might be present in the
Belgium population, we screened 200 control individuals.
No individual carrying this speciﬁc amplicon could be
detected.
Among the genes located in the ampliﬁed interval are
olfactory receptor genes, the beta-defensin genes and the
Deubiquitinating enzyme 3 and 4 (DUB) genes. More than
30 genomic locations are known for the olfactory receptor
gene cluster (ORGC), the beta-defensins are present on
chromosomes 4, 8, and 11, and the DUB genes are present
on chromosomes 4, 7, and 8.14,15 The dopamine receptor
D5 gene (DRD5) is the only single-locus gene located in
the ampliﬁed region. Nevertheless, all these genes were
found to be copy number variable in the normal popula-
tion. The ampliﬁcation of these genes cannot explain the
observed phenotype, unless the presence of six copies dra-
matically alters their functional properties. Alternatively,
the ampliﬁcation can generate a long-range effect on gene
expression level.16 However, given that microtia and lacri-
mal-duct anomalies have never been observed in patients
with partial 4p16 deletions, duplications, or transloca-
tions,17,18 this ampliﬁcation is unlikely to involve an al-
tered expression level of a nearby gene. The ampliﬁcation
might rather cause structural modiﬁcations leading to
ectopic expression.11 Another possibility is that two rare
events coincided and that this ampliﬁcation is accompa-
nied by another gain-of-function mutation cosegregating
with this amplicon.
A CNV can be simple in structure, such as a tandem du-
plication or a deletion, or it may involve complex gains or
Figure 3. The LOD Score for Chromosome 4 Calculated from
the 250K SNP Array Analysis of the Affected and Unaffected
Family Members
On the x axis is shown the position on chromosome 4 in megabases
(Mb); on the y axis is shown the corresponding LOD score.
(A) The LOD score for the entire chromosome 4.
(B) Detailed view on the region from 1–25 Mb showing the maxi-
mum LOD score of 3.1–3.79 for the region from 8.2 to 21.0 Mb.The Amlosses of homologous sequences at low-copy repeats in
multiple sites of the genome.12,13 Recently, it has been
shown that benign, simple CNVs may carry risks for com-
plex disease traits.13,18–21 Copy-number variation of com-
plex CNVs including the LCRs is (usually) not taken into
consideration when screening for disease phenotypes by
use of array CGH. This has two reasons: (1) Because these
regions are copy number variable in the normal popula-
tion, changes in copy numbers at these sites are not con-
sidered pathogenic; (2) it is technically difﬁcult if not im-
possible to determine copy-number changes at these loci
because the presence of multiple paralogous sites in the
genome obscures their detection, and even when detected,
the location of the copy-number change cannot be traced.
For this reason, many current commercial array platforms
are devoid of these complex regions. It is the familial occur-
rence and linkage pattern of the phenotype described in
this study that directed us to investigate this speciﬁc LCR
in detail. The association of this ampliﬁcation with a Men-
delian inherited trait suggests, however, that these regions
should be taken into consideration when studying disease
phenotypes.
Although ampliﬁcations that cause cytogenetically
recognizable chromosome aberrations are well known in
Figure 4. Identification of the Aberration on Chromosome 4
(A) Partial karyotype of the patient showing the G-banded normal
and aberrant chromosome 4. On the right, an ideogram of a normal
chromosome 4 is presented.
(B) MFISH analysis showing that only genetic material from chro-
mosome 4 is present in the 4pþ.
(C) Multicolor-banding FISH shows that the chromosome 4p cyto-
genetic anomaly is caused by the 4p15-16 region, and the pink
band is larger on the altered chromosome than on normal one.
(D) Tiling-path array of chromosome 4pter demonstrates the ampli-
fication. The red line indicates the 43 the standard deviation (SD)
threshold.
(E) Copy-number analysis for Genechip (CNAG) view of copy-number
analysis of chromosome 4 by 250K SNP array (Genome Laboratory,
Tokyo University). Red spots represent log2 ratios of the signal
intensities between the sample and the references for each SNP.
The blue line shows the averaged log2 ratios and the green bar the
heterozygous SNPs.erican Journal of Human Genetics 82, 181–187, January 2008 183
Figure 5. Delineation of the Breakpoints of the Amplicon
(A) FISH confirmation of the array CGH data and delineation of the CNV. FISH using (Aa) RP11-689P11 (not amplified), (Ab) RP11-637J21
and (Ae) RP11-751L19 (amplified at 4p16), and (Ac) RP11-264E23 and (Ad) RP11-180A12 (amplified at 4p and multiple loci scattered
across the genome) is shown.
(B) Ensembl view (Ensembl release 45, June 2007) for chr 4p16 (from 8.67 Mb to 9.57 Mb) showing the Ensembl genes, nc RNA genes, the
tiling-path clones, and Redon CNV regions.184 The American Journal of Human Genetics 82, 181–187, January 2008
Table 1. Primers Used for Q-PCR
Primer Forward Primer Reverse Position of the Amplicon on Chr 4 (bp) Number of Copies
AGGCAATCATGAAGTGGATGC GGTAGGACACCACCAGGTCG 8,659,910 2
GTAGCCTCACTGCCCCATACA ATGGTGGACAGTTAACCCCAAA 8,667,208 2
CGCTAAATGCGAGTCCATGA TGTCCACACTTCGCTGCTTAA 8,669,413 2
AAGGCCAGGCAAGCAGTAAG AGCGCGGTTTCTTCATCGT 8,670,551 2
GGCACAACAGCGCTTGGTa GCTGTGAGATGTTCCCCAAACb 8,673,720 6
8,679,358
8,684,996
CCTCAAGTCTTACACTGGCACAAa CCCCAAACACTCCAGATCATTC 8,673,704 6
8,679,342
8,684,980
CTCCCAAAGCAAAGCTTGT CCACCCATTGGTCAGAGAAC 8,780,496 6
TTGGCCTGGGAATTGGAA AAGTGGTTTGCCAAGGACAAA 9,413,780 6
CCCTGGGTATCATATCCTGTTGTC GAGCAACACTAACATTCCCATGAC 9,419,991 6
CTTGTTCACTCCCATGTCTTCAG ATCAAACTGCGAAGAGGGAAA 9,424,070 6
TCACTGGAGATGCAGCTCACATb GCCTTGTGAAGGGA ATGAATG 9,424,148 6
TGCCAGAAAAGTGGAACCCTAA TTGCACATCTCCCATGATAGACTCT 9,424,299 2
GCCCCACAGATACAACTTGTCAA AAGGGCACAAGGCAAATGAG 9,426,001 2
GGAGCTGGACTAGAGTTTGGTCAA CAAGCAATTCCCAGGACAAAG 9,429,390 2
TCTGCCCAGGGTTGCTAGTT CCAGCTGCTAGTTCTGGCTAAGT 9,433,782 2
a The amplicon is in an LCR region; therefore, the primers bind to three loci.
b These primers were used for breakpoint-spanning PCR.cancer cytogenetics, only a few examples of inheritable
ampliﬁcations of euchromatic regions exist.22 Amplicon
structure in these cases has, because of technical difﬁculties,
never been investigated at a molecular level. Equally, the
structure of the recently uncovered copy-number variabil-
ity of low copy repeats has not yet been investigated at a
molecular level. The combination of the techniques used
in this study, however, allowed the detectionof ﬁve tandem
copies of the described amplicon in the affected family
members. Such an ampliﬁcation cannot be explained by
a mere nonallelic homologous-recombination event, the
main mechanism generating duplications in inherited dis-
orders,23 nor by the breakage-fusion-bridge cycles, which
generally explain ampliﬁcations in cancers.24,25 Recently,
adaptive ampliﬁcation has been uncovered as a novel
stress-induced mutation mechanism in Escherichia coli.26
These amplicons have many similarities with those seen
in our family: They are large (with respect to the E. coli
genome), are clonally stable (no copy-number variability
within a clone), and are organized in tandem. How these
amplicons arose remains unclear, but two mechanisms
have been proposed. First, following an initial duplication
that may arise through nonhomologous end joining27,28
or template switching within replication forks,29 subse-The Amquent rounds of unequal crossing over among the repeated
sequence may lead to an increase in copy number. Arguing
against thismodel is that this speciﬁcampliconcouldnotbe
detected as a common variant in the population. Another
possibility is that the ampliﬁcation arises via rolling-circle
ampliﬁcation. In this secondmodel, a circle is formedby an-
nealing broken double-stranded ends (DSEs).When the cir-
cle is closed by ligation, a replication fork can pass repeat-
edly, thus producing numerous tandem copies of the
circularized sequence. Breakage of the circle restores the
DSE, whichwill be reintegrated by nonhomologous recom-
bination.30–32 This hypothesis can explain the ﬁnding of
identically sized fragments and three-base sequencemicro-
homology at the breakpoint; the latter is indicative of
nonhomologous end joining.
In conclusion, this unique novel syndrome reported
here is to our knowledge the ﬁrst Mendelian inherited ge-
netic disorder associated with the ampliﬁcation of a CNV.
This ﬁndingmaywell represent the ﬁrst example of a group
of inherited disorders caused by the ampliﬁcation of large
genomic regions known to be copy number variable and
underscores the need to include these benign CNVs in
genome-wide analyzes when screening for copy-number
imbalances in genetic disorders.(C) Q-PCR result showing the copy numbers of the family members and of the controls for the different primer pairs, estimated with the dCt
method and p53 as a reference gene (primers 50-CCCAAGCAATGGATGATTTGA-30 and 50-GAGCTTCATCTGGACCTGGGT-30). The relative location
of the primers to the amplified region is shown with colored bars. Dark blue is for the primer located at 8.6672 Mb, gray is for the one at
8.7802 Mb, purple is for the one at 9.4241 Mb, and light blue is for the one at 9.4242 Mb. The numbers indicating the family members are
the same as in Figure 2. The colors in the graphic correspond to the different amplicons. The duplication control is a patient with t(4,8)
with breakpoint at the ORGC region.erican Journal of Human Genetics 82, 181–187, January 2008 185
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